Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 28;3(8):e10215. doi: 10.1002/jbm4.10215

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors. JBMR Plus Published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Case 1 (A) Coronal T2 (top) and sagittal T2 (bottom) MR images of the right foot at baseline, after 6 months of bisphosphonate therapy, and at follow‐up after 3 months of teriparatide therapy. (B) Biochemical response with levels of alkaline phosphatase (ALP), bone‐specific alkaline phosphatase (BAP), osteocalcin (OC), pyridoxal 5’‐phosphate (PLP), calcium, and phosphate after cessation of treatment with ibandronate and onset of therapy with teriparatide. Grey areas represent reference range. MRI showed improvement and the laboratory report displayed a positive biochemical response.